Dr. Tony Reiman, MD, SM, FRCPC
Canadian Cancer Society Research Chair, University of New Brunswick;
Medical Oncologist, Saint John Regional Hospital;
Assistant Dean, Research, Dalhousie Medicine New Brunswick
Dalhousie University; Saint John Regional Hospital, Saint John, NB
Myeloma, lung cancer, lymphoma; cancer clinical trials; translational cancer research; multidisciplinary supportive cancer care research.
Involving patients in cutting edge cancer research
As a practicing medical oncologist, my interest lies in involving patients in research to improve their care. This includes banking of biological specimens and clinical data for research, clinical trials of new therapeutic approaches and multidisciplinary supportive care research in areas such as body composition and exercise.
Membership Status:Dr. Reiman is a BHCRI Senior Scientist, a member of the BHCRI Training Committee and was a presenter at the 2010 BHCRI Symposium.
Address:Department of Oncology, Saint John Regional Hospital, 400 University Avenue, Saint John, New Brunswick, Canada E2L 4L2
Palumbo A, Sezer O, Kyle R, Miguel JS, Orlowski RZ, Moreau P, Niesvizky R, Morgan G, Comenzo R, Sonneveld P, Kumar S, Hajek R, Giralt S, Bringhen S, Anderson KC, Richardson PG, Cavo M, Davies F, Bladé J, Einsele H, Dimopoulos MA, Spencer A, Dispenzieri A, Reiman T, Shimizu K, Lee JH, Attal M, Boccadoro M, Mateos M, Chen W, Ludwig H, Joshua D, Chim J, Hungria V, Turesson I, Durie BG, Lonial S. International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation. Leukemia. 2009 Jun 4. [Epub ahead of print]
Courneya KS, Sellar CM, Stevinson C, McNeely ML, Peddle CJ, Friedenreich CM, Tankel K, Basi S, Chua N, Mazurek A, Reiman T. Effects of aerobic exercise on physical functioning and quality of life in lymphoma patients: a randomized controlled trial. Journal of Clinical Oncology (In Press 2009).
Tonelli M, Hemmelgarn B, Reiman T, Manns B, Reaume MN, Lloyd A, Wiebe N, Klarenbach S. Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysis. CMAJ. 2009 Apr 30. [Epub ahead of print]
Jones LW, Eves ND, Peddle CJ, Courneya KS, Haykowsky M, Kumar V, Winton TW, Reiman T. Effects of presurgical exercise training on systemic inflammatory markers among patients with malignant lung lesions. Appl Physiol Nutr Metab. 2009 Apr;34(2):197-202.
Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, Baracos VE. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008 Jul;9(7):629-35. Epub 2008 Jun 6.
Kirshner, J., Thulien, K.J., Martin, L.D., Debes Marun, C., Reiman, T. Belch, A.R., Pilarski, L.M. A Unique 3-D model for evaluating the impact of therapy on Multiple Myeloma. Blood. 2008 Jun 5. [Epub ahead of print].
Robert P. Evans, Claudia Naber, Tara Steffler, Tamara Checkland, Jonathan J. Keats, Christopher A. Maxwell, Troy E. Perry, Heidi Chau, Andrew R. Belch, Linda M. Pilarski and Tony Reiman. Aurora A kinase RNAi and small molecule inhibition of Aurora kinases with VE-465 induce apoptotic death in multiple myeloma cells. Leuk Lymphoma. 2008 Mar;49(3):559-69.
Lee W. Jones, Neil D. Eves, John R. Mackey, Carolyn J. Peddle, Mark Haykowsky, Anil A. Joy, Keith Tankel, Kerry S. Courneya, and Tony Reiman. Systemic Inflammation, Cardiorespiratory Fitness, and Quality of Life in Patients with Advanced Non-Small Cell Lung Cancer (letter). J Thorac Oncol. 2008 Feb;3(2):194-5.
Robert P. Evans, Claudia Naber, Tara Steffler, Tamara Checkland, Christopher A. Maxwell, Jonathan J. Keats, Andrew R. Belch, Linda M. Pilarski, Raymond Lai and Tony Reiman. The selective Aurora B kinase inhibitor AZD1152 is a potential new treatment for multiple myeloma. British Journal of Haematology, 2008 Feb;140(3):295-302.
Jones LW, Peddle CJ, Eves ND, Haykowsky MJ, Courneya KS, Mackey JR, Joy AA, Kumar V, Winton TW, Reiman T. Effects of presurgical exercise training on cardiorespiratory fitness among patients undergoing thoracic surgery for malignant lung lesions. Cancer 2007 Aug 1;110(3):590-8.
Chung R, Lai R, Wei P, Lee J, Hanson J, Belch AR, Turner AR, Reiman T. Concordant but not discordant bone marrow involvement in diffuse large B-cell lymphoma predicts a poor clinical outcome independent of the international prognostic index. Blood. 2007 Aug 15;110(4):1278-82. Epub 2007 May 2.
Sève P, Lai R, Ding K, Winton T, Butts C, Mackey J, Dumontet C, Dabbagh L, Ronen S, Seymour L, Tsao M, Shepherd F, Reiman T. Class III beta tubulin expression and benefit from adjuvant cisplatin/vinorelbine chemotherapy in operable non-small cell lung cancer: analysis of NCIC JBR.10. Clinical Cancer Research 2007 Feb 1;13(3):994-9.
Jones LW, Eves ND, Mackey JR, Peddle CJ, Haykowsky M, Joy AA, Tankel K,Courneya KS, Spratlin J, Reiman T. Safety and feasibility of cardiopulmonary exercise testing in patients with advanced cancer. Lung Cancer. 2007 Feb;55(2):225-32. Epub 2006 Nov 17.
Maxwell CA, Keats JJ, Belch AR, Pilarski LM, Reiman T. Receptor for hyaluronan-mediated motility correlates with centrosome abnormalities in multiple myeloma and maintains mitotic integrity. Cancer Res. 2005 Feb 1;65(3):850-60.
Maxwell CA, Rasmussen E, Zhan F, Keats JJ, Adamia S, Strachan E, Crainie M, Walker R, Belch AR, Pilarski LM, Barlogie B, Shaughnessy J Jr, Reiman T. RHAMM expression and isoform balance predict aggressive disease and poor survival in multiple myeloma. Blood. 2004 Aug 15;104(4):1151-8. Epub 2004 Apr 22.
Keats JJ, Reiman T, Maxwell CA, Taylor BJ, Larratt LM, Mant MJ, Belch AR, Pilarski LM. In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression. Blood. 2003 Feb 15;101(4):1520-9. Epub 2002 Oct 3.